Amphenol Corporation & Affiliated Companies

Wallingford, CT ManufacturingNAICS 334410

Self-funded health planPlan year 2025Renews January
9,058Participants+18% vs. prior year
$21.5MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#2 of 34Manufacturing in CTBy participants

Overview

Amphenol Corporation & Affiliated Companies sponsors a self-funded health plan that covered 9,058 participants in plan year 2025, up 18% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
9,058 · prior year 7,707
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Group Employee Benefits Plan of Amphenol Corporation, plan 501 (9,058 participants)
Stop-loss carrier
Sun Life Assurance Company of Canada
Broker compensation
$1.0M across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disability

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
CVS Pharmacy, Inc.Medical, Prescription drug10,250$30.9M—
Hartford Life and AccidentLife, Long-term disability9,437$8.2M$571K
Delta Dental of NJ, Inc.Dental9,751$4.8M—
Kaiser Foundation Health Plan, Inc.Medical, HMO132$2.2M$117K
Sun Life Assurance Company of CanadaStop-loss1,012$1.4M$166K
Anthem Health Plans, Inc.Vision12,268$833K—
The Hartford Life Insurance CompanyShort-term disability650$662K$36K
Federal Insurance CompanyAD & D, AD&D6,256$372K$56K
United American Insurance CompanyMedical81$225K$40K
ElixirMedical, Prescription drug74$122K$12K
Ace Insurance CompanyAD & D6,256$34K$7K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$21.5M/ year

Estimated prescription spend: 9,058 participants × $2,371 national average per member. Usually higher once dependents are counted.

$558K–$1.4M/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$163K–$408K
Lower-cost therapeutic alternatives$238K–$498K
Generic pricing vs. actual cost$103K–$309K
PBM contract terms$54K–$161K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Amphenol Corporation & Affiliated Companies
Sponsor EIN
22-2785165
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 22-2785165 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Amphenol Corporation Employee Savings/401(k) Plan
Type
401(k) plan
Participants
10,313

About this data

Source: Amphenol Corporation & Affiliated Companies's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Amphenol Corporation & Affiliated Companies.

Request a correction · Methodology